Source link : https://www.newshealth.biz/health-news/meta-analysis-probes-rare-potential-vision-risk-from-glp-1s/
TOPLINE: Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately prescribed for obesity or diabetes. METHODOLOGY: A retrospective observational study recently suggested that semaglutide treatment may be associated with more than a fourfold increase in the risk for […]
Author : News Health
Publish date : 2024-12-06 12:43:30
Copyright for syndicated content belongs to the linked Source.